To read perimenopause lab results, start with the test name, your lab’s reference range, and the reason the test was ordered. Follicle-stimulating hormone (FSH) and estrogen can rise and fall during the transition, so one result cannot reliably confirm or rule out perimenopause. Clinicians interpret numbers alongside your age, period pattern, symptoms, medicines, and other possible causes of the changes.
Why can perimenopause lab results be difficult to interpret?
Perimenopause is the transition leading up to menopause. During this time, ovarian hormone production changes, and hormone levels can fluctuate from one menstrual cycle to another. As a result, a blood test may show a hormone level within the usual range for someone who is still menstruating, even when menstrual changes or other symptoms have begun.
The American College of Obstetricians and Gynecologists (ACOG) explains that hormone testing is generally unnecessary to identify perimenopause in people aged 45 and older when the typical symptoms and menstrual changes are present. A single result may not reflect the broader hormonal changes occurring over time.
This means a laboratory report should not be read as a simple pass-or-fail test. A result marked “normal” does not necessarily exclude perimenopause, and a result marked “high” or “low” does not automatically establish it. The meaning depends on the specific hormone tested, the timing of the blood sample, the laboratory's reference range, your age, and your clinical history.
How should you read the numbers on a lab report?
Before interpreting individual hormones, look at four parts of your report: the test name, the numerical result, the unit of measurement, and the reference range supplied by the laboratory. Some reports also identify results as high, low, or outside the expected range. These flags indicate how the result compares with that laboratory's reference interval; they do not, by themselves, provide a diagnosis.
Reference ranges can differ between laboratories because testing methods and reporting units may vary. Hormone results can also depend on whether you are still having periods, the phase of your menstrual cycle, your age, and whether you use hormonal medication. MedlinePlus advises interpreting FSH results in light of age, symptoms, medical history, and other test results rather than relying on the number alone.
For example, two people with the same FSH result may need different interpretations if one is in their early 30s and the other is in their late 40s. A result also may have a different meaning depending on whether a person is menstruating regularly, has missed several periods, or is taking hormonal contraception. Avoid comparing your result with an isolated number found online unless the age group, testing method, units, and clinical context are comparable.
What do the main perimenopause hormone tests mean?
Follicle-stimulating hormone (FSH)
FSH is a hormone produced by the pituitary gland, a small gland at the base of the brain. It helps regulate the menstrual cycle and supports the development of eggs in the ovaries. As ovarian function changes during the menopause transition, FSH may rise because the body is sending stronger signals to the ovaries.
How to interpret it: A higher FSH level may be consistent with declining ovarian function, but it is not a reliable standalone measure of perimenopause. Levels can change considerably during the transition, so one high reading may not represent the person's usual hormone pattern. A result within the laboratory's expected range does not rule out perimenopause either.
When reviewing FSH, check whether your report provides a reference range for people who are still menstruating or for those who have reached menopause. These ranges may differ. The relevant comparison also depends on your age and, when applicable, the timing of the blood draw within your menstrual cycle.
Estradiol (E2), a form of estrogen
Estradiol is a major form of estrogen during the reproductive years. It helps regulate the menstrual cycle and supports several body functions. During perimenopause, estradiol levels can rise and fall rather than declining steadily from one test to the next.
How to interpret it: A low estradiol result may reflect lower estrogen levels at the time of testing, but one result cannot reliably establish where you are in the menopause transition. A normal or higher result also does not exclude perimenopause, because ovarian hormone production can continue to fluctuate.
FSH and estradiol are sometimes measured together, particularly when a clinician is investigating changes in menstrual periods at a younger age. The two results should be reviewed as a pair, along with symptoms, cycle history, and relevant medication use. Neither result should be treated as a universal cutoff for perimenopause.
Anti-Müllerian hormone (AMH)
AMH is a hormone produced by cells in developing ovarian follicles. It is used in certain reproductive evaluations, but it is not a dependable standalone test for confirming that perimenopause has started. A result that appears low or high cannot, by itself, tell you whether current symptoms are caused by the menopause transition or determine the exact time until menopause.
For people aged 45 and older, the National Institute for Health and Care Excellence (NICE) advises against using AMH, estradiol, inhibin tests, or ovarian imaging measurements to identify perimenopause or menopause. These tests are not routinely needed for that purpose in this age group.
Luteinizing hormone (LH) and progesterone
LH helps regulate ovulation, while progesterone usually rises after ovulation during a menstrual cycle. Both hormones may be included in selected reproductive or menstrual investigations. Their interpretation depends on the clinical question and, for some tests, the timing of the sample.
How to interpret them: An LH or progesterone value should not be used on its own to confirm or exclude perimenopause. If either appears on your report, ask why it was ordered and what the clinician expected it to help clarify. These tests may provide additional information in a specific clinical situation, but they do not replace an assessment of menstrual changes and symptoms.
What does a high or low FSH result actually mean?
A high FSH result means that the measured level was above the laboratory's reference interval for the comparison group shown on the report. Depending on age and clinical circumstances, it may be consistent with changing ovarian function. However, high FSH levels can occur for reasons other than the usual menopause transition, so the result needs to be interpreted in context.
A low or in-range FSH result also needs context. It may occur when the ovaries are still functioning, but it does not necessarily mean that perimenopause is absent. Hormone levels can vary over time, and medicines or other health conditions can affect the pattern.
There is no single FSH threshold that reliably confirms perimenopause in every person. It is more useful to understand why the test was ordered, whether the result fits the menstrual and symptom history, and whether repeat testing or an assessment for another cause is appropriate.
How does your age change the interpretation?
Age is important because the recommended approach to menopause assessment differs for people in their mid-40s and older compared with those experiencing possible menopause-related changes at a younger age.
Age 45 and older
In otherwise healthy people aged 45 and older who have typical menopause-associated symptoms and recent changes in their menstrual cycle, clinicians can usually identify perimenopause from the history rather than hormone blood tests. Symptoms may include newly occurring hot flushes or night sweats alongside irregular periods. Routine FSH testing is generally not needed to establish the transition.
Age 40 to 45
When menopause-associated symptoms and menstrual changes occur between ages 40 and 45, a clinician may consider an FSH test if the result would help clarify the situation. The decision depends on the symptoms, menstrual history, medication use, and whether another explanation needs to be investigated. A blood test is not automatically necessary for everyone in this age group.
Under age 40
When menopause-related changes are suspected before age 40, assessment is particularly important because early loss of ovarian function may require a different evaluation and follow-up. NICE recommends considering FSH testing when primary ovarian insufficiency is suspected and diagnosing the condition using the clinical history and elevated FSH results from two blood samples taken four to six weeks apart. A single abnormal result should not be used to establish this diagnosis.
These age-related recommendations are important when reviewing a result that appears outside the expected range. The same numerical result may lead to different next steps depending on whether the clinician is assessing typical perimenopause, possible early menopause, or a condition that affects ovarian function.
Can medication or the timing of the test affect your results?
Yes. Hormone results must be interpreted alongside the medicines and hormonal treatments you use. Combined hormonal contraception and high-dose progestogen can affect how menopause-related changes are assessed. Other prescribed hormone treatments may also make it more difficult to interpret a result in isolation.
NICE specifically advises against using an FSH blood test to identify menopause in people taking combined estrogen and progestogen contraception or high-dose progestogen. Tell your clinician about contraceptive pills, injections, implants, hormonal intrauterine devices, and menopause hormone therapy when discussing your report. Do not stop or change prescribed medication simply to obtain a test result unless your healthcare professional specifically advises you to do so.
Timing matters, too. FSH and other reproductive hormones may vary across the menstrual cycle. If you are still having periods, your clinician may request a blood sample on a particular cycle day for a specific reason. If your periods are irregular or have stopped, let the clinician know when your last period occurred and whether you use hormonal contraception.
Why might a clinician order tests other than hormone tests?
Not every change in menstrual bleeding or every menopause-like symptom is caused by perimenopause. Depending on your history and examination, a clinician may order tests to look for another explanation or to assess a complication associated with bleeding. The purpose of these tests differs from measuring FSH or estradiol.
For example, a pregnancy test may be appropriate when pregnancy is possible, while a complete blood count may be used to check for anemia when bleeding is heavy or prolonged. ACOG's guidance on abnormal uterine bleeding describes these tests as part of an evaluation when they are clinically indicated. Other investigations depend on the person's symptoms, age, medical history, and examination findings.
Bleeding between periods, bleeding after sex, unusually heavy or prolonged periods, or bleeding after menopause should be discussed with a healthcare professional rather than attributed automatically to perimenopause. If bleeding is very heavy and you feel faint, very weak, short of breath, or otherwise acutely unwell, seek urgent medical assessment.
What should you do after receiving your results?
Start by reading the entire report rather than focusing only on the high or low flags. Note which hormones were measured, the units used, the reference intervals, and any comments from the laboratory. Compare the results with the reason for testing and the timing of the blood sample, then discuss any unclear values with the clinician who ordered the tests.
It can also help to keep a record of menstrual changes and symptoms before your appointment. Note when your periods start and stop, any missed cycles, changes in bleeding, hot flushes, night sweats, sleep problems, or other experiences that affect daily life. Include relevant medical history and a list of medicines and supplements so the clinician can interpret the results more accurately.
Useful questions to ask include:
- What was each test intended to investigate?
- Does this result make sense in relation to my age, symptoms, and menstrual history?
- Could my medication or the timing of the blood sample affect the result?
- Do I need repeat testing, or would another type of assessment be more useful?
- Are there any symptoms or bleeding changes that need further investigation?
If your results are unclear, do not assume that you need every hormone test repeated. Your clinician can decide whether another sample would meaningfully answer the clinical question or whether your symptoms and history provide the information needed. The aim is to understand the overall pattern and identify any concerns that require follow-up, not to reach a conclusion from one number.